Polen Capital Regeneron Pharmaceuticals, Inc. Transaction History

Polen Capital Management LLC

$38.7 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$548.35 - $738.84 $758,368 - $1.02 Million	-1,383 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$595.12 - $698.43 $330,291 - $387,628	-555 Reduced 28.64%	1,383 $966,000
Q4 2021 Feb 11, 2022	SELL	$543.48 - $670.97 $117,935 - $145,600	-217 Reduced 10.07%	1,938 $1.22 Million
Q3 2021 Nov 10, 2021	BUY	$574.03 - $680.96 $1.24 Million - $1.47 Million	2,155 New	2,155 $1.3 Million
Q1 2021 May 12, 2021	SELL	$446.73 - $548.2 $895 Million - $1.1 Billion	-2,002,804 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$478.3 - $607.98 $31.2 Million - $39.6 Million	65,147 Added 3.36%	2,002,804 $968 Million
Q3 2020 Nov 12, 2020	BUY	$544.75 - $658.21 $50.7 Million - $61.3 Million	93,123 Added 5.05%	1,937,657 $1.08 Billion
Q2 2020 Aug 13, 2020	BUY	$493.32 - $643.92 $60.9 Million - $79.5 Million	123,532 Added 7.18%	1,844,534 $1.15 Billion
Q1 2020 May 11, 2020	BUY	$336.18 - $494.43 $15 Million - $22.1 Million	44,708 Added 2.67%	1,721,002 $840 Million
Q4 2019 Feb 06, 2020	BUY	$274.13 - $376.51 $9.34 Million - $12.8 Million	34,084 Added 2.08%	1,676,294 $629 Million
Q3 2019 Nov 12, 2019	BUY	$273.46 - $318.39 $15.6 Million - $18.2 Million	57,097 Added 3.6%	1,642,210 $456 Million
Q2 2019 Aug 12, 2019	SELL	$299.6 - $414.82 $5.23 Million - $7.24 Million	-17,448 Reduced 1.09%	1,585,113 $496 Million
Q1 2019 May 13, 2019	BUY	$372.08 - $439.57 $43.6 Million - $51.6 Million	117,306 Added 7.9%	1,602,561 $658 Million
Q4 2018 Feb 12, 2019	SELL	$335.82 - $403.04 $1.09 Million - $1.3 Million	-3,237 Reduced 0.22%	1,485,255 $555 Million
Q3 2018 Nov 13, 2018	BUY	$351.14 - $408.51 $1.71 Million - $1.98 Million	4,858 Added 0.33%	1,488,492 $601 Million
Q2 2018 Aug 09, 2018	BUY	$284.6 - $344.99 $18.4 Million - $22.2 Million	64,493 Added 4.54%	1,483,634 $512 Million
Q1 2018 May 11, 2018	BUY	$315.82 - $393.78 $9.35 Million - $11.7 Million	29,596 Added 2.13%	1,419,141 $489 Million
Q4 2017 Feb 09, 2018	BUY	$358.63 - $469.95 $5.71 Million - $7.49 Million	15,931 Added 1.16%	1,389,545 $522 Million
Q3 2017 Nov 13, 2017	BUY	$431.38 - $504.0 $593 Million - $692 Million	1,373,614	1,373,614 $614 Million

Others Institutions Holding REGN

# of Institutions

1,529

Shares Held

84.1M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track Polen Capital's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Polen Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Polen Capital Management LLC and Polen Capital with notifications on news.

Account